InvestorsHub Logo
Followers 10
Posts 362
Boards Moderated 0
Alias Born 06/22/2018

Re: postes post# 349928

Monday, 08/09/2021 5:19:35 PM

Monday, August 09, 2021 5:19:35 PM

Post# of 423944
The validated mfg processes will ensure that. The pilot studies are carries out precisely for these reasons.
Unless the companies decide to ditch all the cGMP protocols , the drugs will meet the standards.

There better be good reason for generics to not only launch at risk but now also take steps to ditch mfg standards and also be liable for patients lawsuits.

I an curious what reasons would justify for companies to take this route for a $10-15 million market share?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News